Multimodal treatment in oligometastatic gastric cancer

doi:10.4251/wjgo.v14.i2.434

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4893)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

293

WORD

HTML

2690

Figures (1-3)

344

Tables (1-1)

307

Sum=3728

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

385

Download

780

Sum=1165

Feb 15, 2022 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Feb 15, 2022; 14(2): 434-449
Published online Feb 15, 2022. doi: 10.4251/wjgo.v14.i2.434

Full Size Figure Download Figure

Figure 2 Diagram of the FLOT-5 RENAISSANCE Trial comparing chemotherapy alone vs surgical resection for oligometastatic gastric cancer. FLOT: Fluorouracil, leucovorin, oxaliplatin and docetaxel.

Citation: Chevallay M, Wassmer CH, Iranmanesh P, Jung MK, Mönig SP. Multimodal treatment in oligometastatic gastric cancer. World J Gastrointest Oncol 2022; 14(2): 434-449
URL: https://www.wjgnet.com/1948-5204/full/v14/i2/434.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i2.434